Written and maintained by CASRAI Editorial Board
Last updated
Medical Disclaimer: This guide provides technical, regulatory, and material specifications for researchers, clinical engineers, and procurement staff. It does not constitute clinical practice guidelines or individual medical advice.
Short answer
Orthopedic implants are biocompatible medical devices surgically placed inside the body to stabilize, support, or replace damaged bones, joints, and cartilage. Regulated primarily as Class II devices under FDA 21 CFR Part 888, they encompass temporary fracture fixation hardware (plates, screws, intramedullary rods), permanent arthroplasty joint prostheses (hip and knee replacements), and spinal fusion systems.
Definition and scope
An orthopedic implant is an internal medical device fabricated from biocompatible metals, polymers, ceramics, or composites intended to interface with skeletal tissue for extended or permanent durations. Implants differ from external orthoses (braces and splints) and reusable orthopedic surgical instruments used during operative procedures.
In the United States, orthopedic implants are governed by the U.S. Food and Drug Administration (FDA) under Title 21 of the Code of Federal Regulations (21 CFR Part 888). Most load-bearing implants are designated as a Class II medical device, requiring a 510(k) Premarket Notification demonstrating substantial equivalence to a predicate device. Class II clearance mandates compliance with FDA special controls, ASTM material standards, and biological safety testing under ISO 10993.
The clinical scope includes four primary operational categories:
- Trauma Fixation: Plates, screws, and intramedullary rods stabilizing fractures during healing.
- Joint Arthroplasty: Prosthetic components replacing articulating surfaces in the hip, knee, and shoulder.
- Spinal Arthrodesis: Pedicle screws, rods, and interbody cages that fuse spinal segments.
- Soft Tissue Fixation: Anchors and interference screws securing tendons or ligaments to bone.
How orthopedic implants work in practice
Orthopedic implants function through mechanical load transfer and biological tissue integration. Clinical performance relies on immediate primary mechanical stability followed by lasting secondary biological fixation.
Primary mechanical stability is achieved intraoperatively through geometric press-fit interference, screw compression, or acrylic fixation using polymethylmethacrylate bone cement (21 CFR § 888.3027). Acrylic cement acts as a viscoelastic grout distributing stresses across the bone-implant interface. In cementless designs, primary stability relies on press-fit frictional hold.
Secondary biological stability develops over months through osseointegration—direct structural bonding between living bone and the implant surface. Surface textures, porous titanium coatings, and hydroxyapatite encourage osteoblasts to deposit mineralized bone matrix into microscopic pores.
Managing elastic modulus (stiffness) relative to human cortical bone (~10 to 20 GPa) is critical. Implants with excessive stiffness—such as cobalt-chromium alloy (210 to 240 GPa) or stainless steel (~200 GPa)—absorb all physiological load, causing stress shielding. Under Wolff’s law, unstressed bone resorbs. Engineers mitigate stress shielding by using lower-modulus titanium alloys (~110 GPa) or polyetheretherketone (PEEK, ~3.6 GPa).
Biocompatibility is evaluated under ISO 10993, verifying that materials are non-cytotoxic (ISO 10993-5), cause no adverse local tissue reaction (ISO 10993-6), and exhibit no systemic toxicity (ISO 10993-11).
Types and biomaterials comparison
Orthopedic implants are manufactured from biomaterials meeting strict metallurgical and mechanical standards. The table below compares primary implant categories under 21 CFR Part 888, consensus material specifications, and clinical applications.
| Implant Category | FDA Regulation | FDA Class | Material Specification | Key Properties | Clinical Applications |
|---|---|---|---|---|---|
| Bone Plates and Accessories | 21 CFR § 888.3030 | Class II | ASTM F138 (316L) / ASTM F136 (Ti-6Al-4V ELI) | Tensile strength ≥860 MPa; formable for anatomical contouring. | Diaphyseal and periarticular fracture fixation. |
| Bone Fasteners and Screws | 21 CFR § 888.3040 | Class II | ASTM F136 (Ti-6Al-4V) / ASTM F138 (316L) | High shear strength; low carbon (≤0.03 wt.%) resists corrosion. | Cortical, cancellous, and lag screw compression. |
| Intramedullary Rods | 21 CFR § 888.3020 | Class II | ASTM F136 (Ti-6Al-4V ELI) / ASTM F75 (Co-Cr-Mo) | Fatigue resistance under cyclic bending; axial load-sharing. | Femoral, tibial, and humeral shaft fractures. |
| Hip Joint Prostheses | 21 CFR § 888.3350 | Class II | ASTM F75 (Co-Cr-Mo) / ASTM F648 (UHMWPE) | High wear resistance; low friction bearing articulation. | Total and hemi-hip arthroplasty for osteoarthritis. |
| Spinal Interbody Cages | 21 CFR § 888.3080 | Class II | ASTM F2026 (PEEK) / ASTM F136 (Titanium) | PEEK modulus (~3.6 GPa) matches bone; radiolucent. | Interbody spinal fusion and disc height restoration. |
Where it matters for labs, clinics or supply decisions
Orthopedic hardware represents a high-cost inventory category requiring coordination between central sterile supply departments (CSSD), operating room (OR) materials managers, and clinical engineering.
Because patient anatomy and fracture geometries vary widely, hospitals cannot predict exact component sizes before surgery. Facilities manage this variability through consignment stock agreements. Under consignment models, device manufacturers place multi-tray implant sets in hospital storage. Ownership remains with the vendor until an implant is deployed during surgery, triggering electronic replenishment and billing.
Supply workflows manage two packaging formats:
- Pre-Sterilized Implants: Joint prostheses and PEEK cages arrive gamma-irradiated in double-barrier blister packs with barcoded lot data.
- Non-Sterile Consigned Sets: Standard trauma plates and screws arrive in modular caddies that CSSD staff must reprocess and autoclave before each case.
Traceability at point of care is enforced through FDA Unique Device Identification (UDI). OR teams scan device and production identifier barcodes directly into the electronic health record. This data integrates with post-market surveillance registries, such as the American Joint Replacement Registry (AJRR) and the National Joint Registry (NJR), which track long-term revision rates and implant survival.
Common misunderstandings
Several clinical and material misconceptions surround orthopedic implants:
- Misunderstanding: All metal implants release toxic ions and cause systemic hypersensitivity.
Fact: Modern implants use titanium alloys (ASTM F136) and cobalt-chrome (ASTM F75) that form passive surface oxide films (TiO₂ and Cr₂O₃), providing superior corrosion resistance. Bearing surfaces now rely on ceramics or cross-linked polyethylene, preventing metallic wear debris. - Misunderstanding: Stiffer and stronger materials always produce better orthopedic implants.
Fact: Excessive implant stiffness causes stress shielding. Under Wolff’s law, unstressed bone resorbs. Lower-modulus biomaterials—such as titanium alloys (~110 GPa) and PEEK (~3.6 GPa)—promote physiological strain distribution and preserve bone. - Misunderstanding: Every orthopedic implant remains in the body permanently.
Fact: Implants divide into permanent joint reconstructions and temporary fracture fixation devices. Plates, screws, and rods stabilize bone until union is achieved and are often removed post-healing. Bioabsorbable polymers (21 CFR § 888.3044) degrade hydrolytically over 12 to 24 months, avoiding secondary surgery. - Misunderstanding: Patients with orthopedic implants cannot undergo MRI scans.
Fact: Contemporary orthopedic implants are classified as MR Conditional under ASTM F2503. Non-ferromagnetic titanium alloys, cobalt-chromium alloys, PEEK, and ceramics do not exhibit hazardous magnetic deflection. Device labeling specifies safe magnetic field strengths and absorption limits.
Frequently asked questions
What materials are most commonly used in orthopedic implants?
Orthopedic implants are fabricated from metallic alloys, polymers, and ceramics. Metals include titanium alloys (Ti-6Al-4V ELI per ASTM F136) for strength and osseointegration, cobalt-chromium-molybdenum (Co-Cr-Mo per ASTM F75) for wear-resistant bearings, and 316L stainless steel (ASTM F138) for trauma fixation. Polymers include ultra-high-molecular-weight polyethylene (UHMWPE per ASTM F648) for joint bearings and polyetheretherketone (PEEK per ASTM F2026) for radiolucent spinal cages.
How does the FDA classify orthopedic implants?
The FDA classifies orthopedic implants under 21 CFR Part 888 (Orthopedic Devices), primarily within Subpart D. Most load-bearing implants are designated as Class II medical devices, requiring a 510(k) Premarket Notification demonstrating substantial equivalence to a predicate device. Class II devices must comply with FDA special controls, ASTM material standards, and ISO 10993 biocompatibility testing.
What is the difference between trauma fixation implants and joint replacement prostheses?
Trauma fixation hardware (plates, screws, and intramedullary rods under 21 CFR § 888.3020 and § 888.3030) temporarily stabilizes fractured bone fragments to facilitate natural biological healing and union. Joint replacement prostheses (total hip and total knee systems under 21 CFR § 888.3350 and § 888.3560) permanently replace articulating joint surfaces, requiring continuous wear resistance and long-term structural fixation.
Sources
- U.S. Code of Federal Regulations. Title 21, Part 888: Orthopedic Devices (Subpart D: Prosthetic Devices, §§ 888.3020, 888.3030, 888.3040, 888.3080, 888.3350). Legal Information Institute, Cornell Law School. Read November 9, 2026. https://www.law.cornell.edu/cfr/text/21/part-888
- U.S. Food and Drug Administration (FDA). Device Classification Database and 510(k) Premarket Notification Guidance. Read November 9, 2026. https://api.fda.gov/device/classification.json
- ASTM International and National Center for Biotechnology Information (NCBI / PMC). Standard Specifications for Medical Implant Materials (ASTM F75, ASTM F136, ASTM F138, ASTM F648, ASTM F2026; ISO 10993 series). Read November 9, 2026. https://www.ncbi.nlm.nih.gov/pmc/
- American Joint Replacement Registry (AJRR) and UK National Joint Registry (NJR). Annual Reports on Joint Arthroplasty Surveillance, Implant Survivorship, and Revision Risk Factors. Read November 9, 2026. https://www.njrcentre.org.uk/
